ArticleImmunology2011

Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.

Camilla A Lindqvist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.